Biohackers seeking to free science and scientific achievement from the ivory tower have come to realize that they may have to borrow from its conventions.
The US Department of Defense (DoD) Office of the Inspector General is conducting a Follow-Up Evaluation of DoD Biological Select Agents and Toxins (BSAT) Biorisk Program Office implementation of recommendations from the April 2016 “Evaluation of DoD Biological Safety and Security Implementation.“
Individual scientists and scientific societies have called for a moratorium on heritable genome editing in humans, but a moratorium raises the question of when does the moratorium end.
China had regulations against germline editing when the scientist edited two female embryos genes using CRISPR to make them (theoretically) resistant to HIV infection.
The biotechnology safety regulations focus on preventing bioterrorism, activities that violate ethics, along with avoiding biosafety hazards.
This report providees researchers and government officials with an understanding of how ethics are created, monitored, and enforced across scientific disciplines and across borders.
While biosecurity experts critically examine the funding sources of biological research, they rarely turn their gaze inward on their own community.
A World Health Organization (WHO) advisory committee on editing human DNA will ask the United Nations agency to establish a global registry of all such research, recommend that editors of scientific journals not publish any unregistered studies, and ask science funders to require that their grantees register their studies.
The federal government has a short list of regulated organisms. But the government’s ban focuses on the organisms themselves, rather than the genetic instructions for making them. Because the government has not published those sequences, the companies must decide for themselves whether a mail order request is potentially dangerous.
Alex Kelly, BioFoundry’s 26-year-old lab manager, compares biotech to the birth of the computer, once cloistered in big corporations, now at everyone’s fingertips. Upskill the people in biotech, Kelly believes, and you’ll get disruption writ large, with a potentially massive payoff for the most disadvantaged.